Literature DB >> 8280693

Recurrent episcleritis associated with adult T cell leukaemia.

K Goto1, M Sugita, K Okada, H Hatano, N Ishiguro, T Yoshiki, S Ohno.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8280693      PMCID: PMC504639          DOI: 10.1136/bjo.77.11.743

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Arabinosylxylotriose mixedly esterified with acetic and ferulic acids from sugar cane bagasse.

Authors:  J Azuma; A Kato; T Koshijima; K Okamura
Journal:  Agric Biol Chem       Date:  1990-08

2.  Adult T-cell leukemia: clinical and hematologic features of 16 cases.

Authors:  T Uchiyama; J Yodoi; K Sagawa; K Takatsuki; H Uchino
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

3.  Ocular manifestations in patients infected with human T-lymphotropic virus type I.

Authors:  N Ohba; M Matsumoto; M Sameshima; Y Kabayama; K Nakao; K Unoki; F Uehara; K Kawano; I Maruyama; M Osame
Journal:  Jpn J Ophthalmol       Date:  1989       Impact factor: 2.447

4.  Infection of human endothelial cells by human T-cell leukemia virus type I.

Authors:  J A Hoxie; D M Matthews; D B Cines
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Orbital T-cell lymphoma in human T-cell leukemia virus-I infection.

Authors:  S A Lauer; J Fischer; J Jones; S Gartner; J Dutcher; J A Hoxie
Journal:  Ophthalmology       Date:  1988-01       Impact factor: 12.079

  5 in total
  2 in total

1.  Adult T-cell leukemia presenting with episcleritis and secondary glaucoma.

Authors:  Shinichirou Oono; Takuji Kurimoto; Hidehiro Oku; Osamu Mimura
Journal:  Jpn J Ophthalmol       Date:  2009-01-30       Impact factor: 2.447

2.  Ocular manifestations and pathology of adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus type 1.

Authors:  Melissa M Liu; Emiko Furusato; Xiaoguang Cao; Defen Shen; Chi-Chao Chan
Journal:  Rare Tumors       Date:  2010-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.